Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Nov 30, 2025 | (FY)Aug 31, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.02%2.92B | 3.48%16.98B | 5.30%3.21B | -4.48%16.41B | -5.71%3.77B | -0.03%5.25B | -12.73%4.34B | 3.18%3.05B | -3.18%17.18B | -3.24%3.99B |
| Cost of revenue | -7.81%1.78B | 9.46%10.27B | 13.12%1.93B | -2.60%9.38B | -1.05%2.2B | 3.61%2.98B | -12.32%2.49B | 1.08%1.71B | -2.32%9.63B | -4.70%2.23B |
| Gross profit | -10.85%1.14B | -4.51%6.71B | -4.67%1.28B | -6.87%7.03B | -11.56%1.56B | -4.45%2.27B | -13.29%1.85B | 5.98%1.34B | -4.24%7.55B | -1.35%1.77B |
| Operating expense | 4.03%726.94M | 3.46%3.13B | 2.35%698.81M | 2.77%3.02B | -1.81%691.18M | 7.48%745.97M | -0.72%904.12M | 7.71%682.76M | 3.25%2.94B | 0.31%703.93M |
| Staff costs | ---- | 4.76%1.22B | ---- | 3.39%1.17B | ---- | ---- | ---- | ---- | -0.73%1.13B | ---- |
| Selling and administrative expenses | ---- | 1.43%747.64M | ---- | 1.86%737.06M | ---- | ---- | ---- | ---- | 10.24%723.63M | ---- |
| -Selling and marketing expense | ---- | -4.25%315.25M | ---- | 0.42%329.25M | ---- | ---- | ---- | ---- | 24.20%327.86M | ---- |
| -General and administrative expense | ---- | 6.03%432.39M | ---- | 3.04%407.81M | ---- | ---- | ---- | ---- | 0.85%395.77M | ---- |
| Depreciation and amortization | ---- | 7.50%142.97M | ---- | -6.59%133M | ---- | ---- | ---- | ---- | -10.25%142.39M | ---- |
| -Depreciation | ---- | 7.50%142.97M | ---- | -6.59%133M | ---- | ---- | ---- | ---- | -10.25%142.39M | ---- |
| Other operating expenses | ---- | 2.89%1.02B | ---- | 4.14%988.22M | ---- | ---- | ---- | ---- | 5.55%948.93M | ---- |
| Operating profit | -28.80%412.49M | -10.52%3.58B | -11.95%579.34M | -13.03%4B | -18.01%872.7M | -9.37%1.52B | -22.61%950.68M | 4.25%657.95M | -8.48%4.6B | -2.41%1.06B |
| Net non-operating interest income (expenses) | 395.02%30.54M | 476.84%61.86M | 494.32%6.17M | 114.12%10.72M | 323.51%6.32M | 82.84%2.14M | 1.41%1.22M | -8.95%1.04M | 108.58%5.01M | 72.80%1.49M |
| Non-operating interest income | 395.02%30.54M | 476.84%61.86M | 494.32%6.17M | 114.12%10.72M | 323.51%6.32M | 82.84%2.14M | 1.41%1.22M | -8.95%1.04M | 108.58%5.01M | 72.80%1.49M |
| Net investment income | 41.63%5.05M | 29.52%7.35M | -30.75%3.57M | 93.68%5.67M | -134.21%-3.28M | -37.27%5.04M | 59.32%-1.24M | 881.64%5.15M | -93.24%2.93M | -107.24%-1.4M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 672K | |||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -186.67%-86K | -30K | -30K | 0 | 0 | 0 | 0 | 0 | 85.10%-1.46M | 84.33%-458K |
| Less:Other special charges | 186.67%86K | --30K | --30K | ---- | ---- | ---- | ---- | ---- | -85.10%1.46M | -84.33%458K |
| Other non-operating income (expenses) | 18.63%15.3M | 0.53%53.39M | 3.14%12.9M | -12.04%53.11M | 53.77%16.11M | -31.53%12.05M | -19.38%12.45M | -25.87%12.5M | -3.47%60.38M | -30.18%10.48M |
| Income before tax | -22.92%463.97M | -9.04%3.71B | -11.04%601.94M | -12.79%4.07B | -17.00%891.85M | -9.67%1.54B | -22.39%963.12M | 4.35%676.65M | -14.57%4.67B | -4.32%1.07B |
| Income tax | -22.23%146.44M | -9.56%1.13B | -11.21%188.3M | -13.36%1.25B | -19.32%265.37M | -8.92%476.14M | -23.63%298.66M | 4.65%212.07M | -14.47%1.45B | -5.34%328.91M |
| Net income | -23.24%317.53M | -8.81%2.57B | -10.96%413.64M | -12.53%2.82B | -15.98%626.49M | -10.00%1.07B | -21.82%664.46M | 4.21%464.57M | -14.61%3.23B | -3.86%745.62M |
| Net income continuous operations | -23.24%317.53M | -8.81%2.57B | -10.96%413.64M | -12.53%2.82B | -15.98%626.49M | -10.00%1.07B | -21.82%664.46M | 4.21%464.57M | -14.61%3.23B | -3.86%745.62M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -23.24%317.53M | -8.81%2.57B | -10.96%413.64M | -12.53%2.82B | -15.98%626.49M | -10.00%1.07B | -21.82%664.46M | 4.21%464.57M | -14.61%3.23B | -3.86%745.62M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -23.24%317.53M | -8.81%2.57B | -10.96%413.64M | -12.53%2.82B | -15.98%626.49M | -10.00%1.07B | -21.82%664.46M | 4.21%464.57M | -14.61%3.23B | -3.86%745.62M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -20.94%10.42 | -6.23%83.24 | -9.29%13.18 | -11.27%88.77 | -14.25%19.85 | -8.71%33.53 | -20.80%20.86 | 5.14%14.53 | -13.59%100.04 | -4.02%23.15 |
| Diluted earnings per share | -20.94%10.42 | -6.23%83.24 | -9.29%13.18 | -11.27%88.77 | -14.25%19.85 | -8.71%33.53 | -20.80%20.86 | 5.14%14.53 | -13.59%100.04 | -3.70%23.15 |
| Dividend per share | 0 | 0.00%60 | 0 | 0.00%60 | 0.00%60 | 0 | 0 | 0 | 0.00%60 | 0.00%60 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |